Dermata Therapeutics Inc

NASDAQ:DRMA  
0.70
+0.01 (+1.38%)
Regulatory, Equity Financing / Related

Dermata Therapeutics Inc Files For Resale Of Up To 7.55 Million Shares Of Our Common Stock By The Selling Stockholder - SEC Filing

Published: 05/04/2022 22:35 GMT
Dermata Therapeutics Inc (DRMA) - Dermata Therapeutics Inc Files for Resale of Up to 7.55 Million Shares of Our Common Stock by the Selling Stockholder - Sec Filing.